What is the recommended dose of propranolol (beta blocker) for migraine prophylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol Dosing for Migraine Prophylaxis

For migraine prevention, start propranolol at 80 mg daily and titrate to a target range of 80-240 mg daily, with most patients achieving optimal control at 160 mg daily. 1, 2, 3

Initial Dosing Strategy

  • Begin with 80 mg once daily (using extended-release formulation if available) 1, 3
  • The FDA label specifies 80 mg as the standard starting dose for migraine prophylaxis 3
  • Immediate-release formulations can be divided into 2-3 daily doses, though extended-release once-daily dosing improves adherence 3

Titration and Target Dosing

  • The usual effective dose range is 160-240 mg once daily 1, 2, 3
  • Increase dosage gradually at 3-7 day intervals until optimal response is achieved 3
  • The American Academy of Family Physicians emphasizes that 160 mg daily represents the average optimal dosage for most patients 1, 4
  • Maximum recommended dose is 240 mg daily for migraine prevention, though the FDA label notes doses up to 640 mg have been used for hypertension 1, 3

Evidence Supporting Lower Doses

Research demonstrates that approximately 73% of patients respond to low doses (≤1 mg/kg body weight, roughly 40-80 mg daily), suggesting you can start conservatively and avoid unnecessary dose escalation 5. However, guidelines consistently recommend the 80-240 mg range as the evidence-based target 1, 2.

Duration of Trial

  • Allow 2-3 months at therapeutic dosing before declaring treatment failure, as clinical benefits may not become apparent immediately 1, 4, 2
  • If no satisfactory response is obtained within 4-6 weeks after reaching maximal dose, discontinue therapy 3

Patient Selection Criteria

Propranolol is indicated when patients have:

  • Two or more migraine attacks per month with disability lasting 3+ days 1, 2
  • Use of acute rescue medications more than twice per week 1
  • Failure of or contraindications to acute migraine treatments 1

Important Contraindications and Monitoring

Absolute contraindications include:

  • Bradycardia or heart block (second or third degree) 1, 2
  • Hypoglycemic episodes 6
  • Hypersensitivity to propranolol 6

Monitor for common adverse effects:

  • Fatigue, depression, nausea, dizziness, and insomnia 1, 2
  • Specifically watch for mood changes and sleep disturbances 1, 2

Critical Pitfall to Avoid

Never use beta-blockers with intrinsic sympathomimetic activity (ISA) for migraine prevention—they are ineffective. 1, 2 Only propranolol and timolol have the strongest evidence for efficacy among beta-blockers 1, 2.

Comparative Considerations

  • Propranolol is superior to amitriptyline for pure migraine (without tension-type features) 1, 4
  • Amitriptyline (30-150 mg daily) is superior for mixed migraine and tension-type headache 1, 4
  • Both are considered first-line agents with equivalent evidence quality 1, 4, 2

Discontinuation

When stopping treatment after achieving stability, withdraw gradually over several weeks, particularly in patients on higher doses, though abrupt cessation is generally safe 3.

References

Guideline

Propranolol Dosing for Migraine Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Migraine Prevention with Beta-Blockers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Preventative Treatments for Occipital Headaches

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The dose of propranolol for migraine prophylaxis. Efficacy of low doses.

Cephalalgia : an international journal of headache, 1989

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.